Journal of the American Heart Association

Article	Citations
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges	289
Degeneration of Bioprosthetic Heart Valves: Update 2020	144
Survival in Children With Congenital Heart Disease: Have We Reached a Peak at 97%?	143
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines	141
Long‐Term PM 2.5 Exposure and Risks of Ischemic Heart Disease and Stroke Events: Review and Meta‐Analysis	134
Potassium Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials	130
Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment	119
Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta‐Analysis	116
Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis	109
Effects of Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patien	107
Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management	106
Pathophysiology of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Review	105
Relation of Different Fruit and Vegetable Sources With Incident Cardiovascular Outcomes: A Systematic Review and Meta‐Analysis of Prospective Cohort Studies	96
Sex Differences in Symptom Presentation in Acute Coronary Syndromes: A Systematic Review and Meta‐analysis	94
Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease	92
Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology	92
Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring	86
Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study	86
Food Insecurity Is Associated With Cardiovascular and All‐Cause Mortality Among Adults in the United States	84
Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018	84
Sex Differences in Heart Failure With Preserved Ejection Fraction	84
Extracorporeal Life Support in Pregnancy: A Systematic Review	83
Ten‐Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs	82
Breastfeeding Is Associated With a Reduced Maternal Cardiovascular Risk: Systematic Review and Meta‐Analysis Involving Data From 8 Studies and 1 192 700 Parous Women	81
Caregiver Influences on Eating Behaviors in Young Children	80

Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial	80
Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta‐Analysis	80
Phenotyping Cardiogenic Shock	76
Statin Use and In‐Hospital Mortality in Patients With Diabetes Mellitus and COVID‐19	74
Coronavirus Disease 2019 (COVID‐19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease	73
Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group	72
Fifteen‐Year Trends in Incidence of Cardiogenic Shock Hospitalization and In‐Hospital Mortality in the United States	68
Risk Factors for Delirium and Cognitive Decline Following Coronary Artery Bypass Grafting Surgery: A Systematic Review and Meta‐Analysis	67
Vascular Smooth Muscle Cells in Aortic Aneurysm: From Genetics to Mechanisms	67
Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals	66
Association of Isolated Coronary Microvascular Dysfunction With Mortality and Major Adverse Cardiac Events: A Systematic Review and Meta‐Analysis of Aggregate Data	66
Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions	65
Shortening Ambulance Response Time Increases Survival in Out‐of‐Hospital Cardiac Arrest	64
Improving Access to Automated External Defibrillators in Rural and Remote Settings: A Drone Delivery Feasibility Study	63
Could Anti‐Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID‐19 Infection? Data From Centers of Southern Italy	63
Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy	62
Prognostic Value of Abdominal Aortic Calcification: A Systematic Review and Meta‐Analysis of Observational Studies	61
Effects of a Vegetarian Diet on Cardiometabolic Risk Factors, Gut Microbiota, and Plasma Metabolome in Subjects With Ischemic Heart Disease: A Randomized, Crossover Study	61
Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention	61
Nonlethal Inhibition of Gut Microbial Trimethylamine N‐oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure	61
Exercise Reduces Ambulatory Blood Pressure in Patients With Hypertension: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials	60
Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change	60
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability	60
Accelerated Early Vascular Aging Among Adolescents With Obesity and/or Type 2 Diabetes Mellitus	59
Alterations in Vascular Function Associated With the Use of Combustible and Electronic Cigarettes	57
Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta‐Analysis	57
The Gut Microbiome of Heart Failure With Preserved Ejection Fraction	57
Nonpharmacologic Interventions for Reducing Blood Pressure in Adults With Prehypertension to Established Hypertension	57
Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial	55
Direct Cardiac Actions of the Sodium Glucose Co‐Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure‐Overload Heart Failure	55
Lead and Cadmium as Cardiovascular Risk Factors: The Burden of Proof Has Been Met	55
Heart Failure Risk Associated With Rheumatoid Arthritis–Related Chronic Inflammation	55
Deep Learning Algorithm for Automated Cardiac Murmur Detection via a Digital Stethoscope Platform	55
Comparison of Multisystem Inflammatory Syndrome in Children–Related Myocarditis, Classic Viral Myocarditis, and COVID‐19 Vaccine‐Related Myocarditis in Children	55
Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study	54
Future Cardiovascular Disease Risk for Women With Gestational Hypertension: A Systematic Review and Meta‐Analysis	54
Association of Isolated Diastolic Hypertension Based on the Cutoff Value in the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines With Subsequent Cardiovascular	53
Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized‐Control	53
Unpredictable Fall of Severe Emergent Cardiovascular Diseases Hospital Admissions During the COVID‐19 Pandemic: Experience of a Single Large Center in Northern Italy	53
Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation	53
Trends in Cardiovascular Mortality Related to Atrial Fibrillation in the United States, 2011 to 2018	53
Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population	52
Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo‐Controlled Trial	52
Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN	52
Age, Sex, and Valve Phenotype Differences in Fibro‐Calcific Remodeling of Calcified Aortic Valve	52
Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis	51
Cardiac Surgery During the Coronavirus Disease 2019 Pandemic: Perioperative Considerations and Triage Recommendations	51
Interstage Home Monitoring for Infants With Single Ventricle Heart Disease: Education and Management	50
Genetic Liability to Depression and Risk of Coronary Artery Disease, Myocardial Infarction, and Other Cardiovascular Outcomes	50
Risk Factor Burden and Long‐Term Prognosis of Patients With Premature Coronary Artery Disease	49

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry	49
Sacubitril/Valsartan Improves Cardiac Function and Decreases Myocardial Fibrosis Via Downregulation of Exosomal miR‐181a in a Rodent Chronic Myocardial Infarction Model	49
Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association	49
Time‐Efficient Inspiratory Muscle Strength Training Lowers Blood Pressure and Improves Endothelial Function, NO Bioavailability, and Oxidative Stress in Midlife/Older Adults With Above‐Normal Blood Pr	48
Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic	48
Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study	47
Angiotensin Receptor‐Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension	47
Effects of Objective and Perceived Social Isolation on Cardiovascular and Brain Health: A Scientific Statement From the American Heart Association	47
All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart	47
National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020	46
Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension	45
Risk Factors for Incident Stroke and Its Subtypes in China: A Prospective Study	45
Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia	45
Long‐Term Survival of Patients With Left Ventricular Noncompaction	45
Predictors of Mortality in Patients With Biopsy‐Proven Viral Myocarditis: 10‐Year Outcome Data	45
National Trends in Heart Donor Usage Rates: Are We Efficiently Transplanting More Hearts?	44
Psychiatric and Psychological Interventions for Depression in Patients With Heart Disease: A Scoping Review	44
Association of Childhood Psychosocial Environment With 30‐Year Cardiovascular Disease Incidence and Mortality in Middle Age	44
Social Determinants of Health and 90‐Day Mortality After Hospitalization for Heart Failure in the REGARDS Study	43
Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID‐19: Derivation and Validation of the HA 2 T 2	43
Longitudinal Assessment of Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children Associated With COVID‐19 Infections	43
Coronary Angiography After Transcatheter Aortic Valve Replacement (TAVR) to Evaluate the Risk of Coronary Access Impairment After TAVR‐in‐TAVR	43
Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors	42
Right Heart Catheterization in Cardiogenic Shock Is Associated With Improved Outcomes: Insights From the Nationwide Readmissions Database	42
In‐Depth Extracorporeal Cardiopulmonary Resuscitation in Adult Out‐of‐Hospital Cardiac Arrest	42
Discontinuity of Cardiac Follow‐Up in Young People With Congenital Heart Disease Transitioning to Adulthood: A Systematic Review and Meta‐Analysis	42
Trends in Prepregnancy Obesity and Association With Adverse Pregnancy Outcomes in the United States, 2013 to 2018	42
Analysis of Posttraumatic Stress Disorder, Depression, Anxiety, and Resiliency Within the Unique Population of Spontaneous Coronary Artery Dissection Survivors	42
Maturation of the Cardiac Autonomic Nervous System Activity in Children and Adolescents	42
Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysms: A Histopathological Evaluation	42
Association of Major Dietary Protein Sources With All‐Cause and Cause‐Specific Mortality: Prospective Cohort Study	41
Association Between Blood Lead Level and Uncontrolled Hypertension in the US Population (NHANES 1999–2016)	41
Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative	41
Redefining Cardiovascular Health to Include Sleep: Prospective Associations With Cardiovascular Disease in the MESA Sleep Study	41
New‐Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long‐Term Outcome: A Population‐Based Nationwide Study From the SWEDEHEART Registry	41
Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries	41
Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials	41
Sleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents	41
Modifiable Risk Factors for Intracranial Aneurysm and Aneurysmal Subarachnoid Hemorrhage: A Mendelian Randomization Study	40
Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas	40
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization	40
Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical Trial	40
Tuberculosis and the Heart	40
Biomechanics of Aortic Dissection: A Comparison of Aortas Associated With Bicuspid and Tricuspid Aortic Valves	39
Automatic Triage of 12‐Lead ECGs Using Deep Convolutional Neural Networks	39
Safety and Efficacy of Leadless Pacemakers: A Systematic Review and Meta‐Analysis	39
Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID‐19	39
Patterns of Postpartum Ambulatory Care Follow‐up Care Among Women With Hypertensive Disorders of Pregnancy	39
Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial	39
Impact of Coronavirus Disease 2019 (COVID‐19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City	39
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta‐Analysis of Randomized Controlled Trials	39
Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mi	38
Coronavirus 2019 Disease (COVID‐19), Systemic Inflammation, and Cardiovascular Disease	38
Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis	38
Medium‐Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry	38
Familial Recurrent Myocarditis Triggered by Exercise in Patients With a Truncating Variant of the Desmoplakin Gene	38
Multi‐Beat Right Ventricular‐Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension	38
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID‐19: Insight From a French Multicenter Cohort Study	38
Association of Changes in Cardiovascular Health Metrics and Risk of Subsequent Cardiovascular Disease and Mortality	38
Area Deprivation Index and Cardiac Readmissions: Evaluating Risk‐Prediction in an Electronic Health Record	38
Longitudinal Plasma Measures of Trimethylamine N‐Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community‐Based Older Adults	38
Sugar‐Sweetened Beverage Intake and Cardiovascular Disease Risk in the California Teachers Study	38
Evaluation of Racial and Ethnic Disparities in Cardiac Transplantation	37
Trends in the Incidence of New‐Onset Hypertensive Disorders of Pregnancy Among Rural and Urban Areas in the United States, 2007 to 2019	37
Recruitment of Black Adults into Cardiovascular Disease Trials	37
Association of Hypertriglyceridemia with All‐Cause Mortality and Atherosclerotic Cardiovascular Events in a Low‐Risk Italian Population: The TG‐REAL Retrospective Cohort Analysis	37
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis	37
Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development	37
Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes	37
Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus	37
Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1‐Year Results of the PENDULUM Registry	36
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation	36
Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program	36
Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young	36
Effects of Sugar‐Sweetened, Artificially Sweetened, and Unsweetened Beverages on Cardiometabolic Risk Factors, Body Composition, and Sweet Taste Preference: A Randomized Controlled Trial	36
Stroke–Heart Syndrome: Recent Advances and Challenges	36
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus	36
Real‐World Analysis of Guideline‐Based Therapy After Hospitalization for Heart Failure	36
SiglecF(HI) Marks Late‐Stage Neutrophils of the Infarcted Heart: A Single‐Cell Transcriptomic Analysis of Neutrophil Diversification	36
High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019	35

Associations of Skeletal Muscle Mass and Fat Mass With Incident Cardiovascular Disease and All‐Cause Mortality: A Prospective Cohort Study of UK Biobank Participants	35
Incidence and Outcomes of Out‐of‐Hospital Cardiac Arrest in Singapore and Victoria: A Collaborative Study	35
Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30‐Day Mortality in COVID‐19	35
Impact of Coronavirus Disease 2019 Pandemic on the Incidence and Management of Out‐of‐Hospital Cardiac Arrest in Patients Presenting With Acute Myocardial Infarction in England	35
Infective Endocarditis After Surgical and Transcatheter Aortic Valve Replacement: A State of the Art Review	35
Consensus Transcriptional Landscape of Human End‐Stage Heart Failure	35
Heart Rate Variability Triangular Index as a Predictor of Cardiovascular Mortality in Patients With Atrial Fibrillation	35
Sex Differences in the Associations of Visceral Adipose Tissue and Cardiometabolic and Cardiovascular Disease Risk: The Framingham Heart Study	34
Clinical Characteristics and Risk Factors of Cardiac Involvement in COVID‐19	34
Machine Learning–Based Risk Assessment for Cancer Therapy–Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients	34
Omega‐3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials	34
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review	34
Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation	34
Sirtuin 3 Alleviates Diabetic Cardiomyopathy by Regulating TIGAR and Cardiomyocyte Metabolism	34
Impact of Chronic Hypertension and Antihypertensive Treatment on Adverse Perinatal Outcomes: Systematic Review and Meta‐Analysis	34
Serum Activity Against G Protein–Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome	34
Clinical Characteristics and Management of Methamphetamine‐Associated Cardiomyopathy: State‐of‐the‐Art Review	33
Cardiac Abnormalities Seen in Pediatric Patients During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: An International Experience	33
Effects of Ambient Air Pollution on Blood Pressure Among Children and Adolescents: A Systematic Review and Meta‐Analysis	33
Comparison of Reperfusion Strategies for ST‐Segment–Elevation Myocardial Infarction: A Multivariate Network Meta‐analysis	33
Relationship Between a Plant‐Based Dietary Portfolio and Risk of Cardiovascular Disease: Findings From the Women's Health Initiative Prospective Cohort Study	33
Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy	33
Defining the Cardiac Fibroblast Secretome in a Fibrotic Microenvironment	33
Highly Sensitive Cardiac Troponins: The Evidence Behind Sex‐Specific Cutoffs	33
Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation	33
Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non‐Obstructive Coronary Arteries: Pathogenic and Prognostic Implications	32
Angiographic Patency of Coronary Artery Bypass Conduits: A Network Meta‐Analysis of Randomized Trials	32
NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus	32
Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID‐19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID‐19 Pandemic	32
Neuropsychological Status and Structural Brain Imaging in Adults With Simple Congenital Heart Defects Closed in Childhood	32
O‐GlcNAcylation Mediates Glucose‐Induced Alterations in Endothelial Cell Phenotype in Human Diabetes Mellitus	32
Knockout of SORBS2 Protein Disrupts the Structural Integrity of Intercalated Disc and Manifests Features of Arrhythmogenic Cardiomyopathy	32
Combined Effects of Physical Activity and Air Pollution on Cardiovascular Disease: A Population‐Based Study	31
Canagliflozin Suppresses Atrial Remodeling in a Canine Atrial Fibrillation Model	31
Predictive Value of the Cardio‐Ankle Vascular Index for Cardiovascular Events in Patients at Cardiovascular Risk	31
Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease	31
Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction	31
First‐Trimester Maternal Folic Acid Supplementation Reduced Risks of Severe and Most Congenital Heart Diseases in Offspring: A Large Case‐Control Study	31
Predictors of Permanent Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement ‐ A Systematic Review and Meta‐Analysis	31
Reversion From Pre–Diabetes Mellitus to Normoglycemia and Risk of Cardiovascular Disease and All‐Cause Mortality in a Chinese Population: A Prospective Cohort Study	31
Trends in Premature Mortality From Acute Myocardial Infarction in the United States, 1999 to 2019	31
Gender Differences in Publication Authorship During COVID‐19: A Bibliometric Analysis of High‐Impact Cardiology Journals	31
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study	31
Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low‐Density Lipoproteins and Increasing Their Uptake by Macrophages	30
Cardiovascular Risk for Patients With and Without Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder	30
Incidence of Hypertension Among US Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos, 2008 to 2017	30
Increased Cardiometabolic and Mortality Risk Following Childhood Maltreatment in the United Kingdom	30
Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020	30
Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives	30
Objective Sleep Efficiency Predicts Cardiovascular Disease in a Community Population: The Sleep Heart Health Study	30
Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25‐Year Nationwide Cohorts	30
Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement	30
Outcomes of Rescue Endovascular Treatment of Emergent Large Vessel Occlusion in Patients With Underlying Intracranial Atherosclerosis: Insights From STAR	30
Excess Mortality and Undertreatment of Women With Severe Aortic Stenosis	30
Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events	30
Impact of Social Frailty in Hospitalized Elderly Patients With Heart Failure: A FRAGILE‐HF Registry Subanalysis	30
Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials	30
Extended‐Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction	29
Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis	29
Coronavirus Disease 2019 and the Cerebrovascular‐Cardiovascular Systems: What Do We Know So Far?	29
Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease	29
Determinants of Pericoronary Adipose Tissue Attenuation on Computed Tomography Angiography in Coronary Artery Disease	29
Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST‐Segment–Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta‐Analysis of Rando	29
Association Between Social Vulnerability Index and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Study	29
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients	29
Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer	29
Causal Effect of Obstructive Sleep Apnea on Atrial Fibrillation: A Mendelian Randomization Study	29
Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction	29
Quantifying the Sex‐Race/Ethnicity‐Specific Burden of Obesity on Incident Diabetes Mellitus in the United States, 2001 to 2016: MESA and NHANES	29
Circulating Vascular Cell Adhesion Molecule‐1 and Incident Heart Failure: The Multi‐Ethnic Study of Atherosclerosis (MESA)	29
Early Growth Response‐1, an Integrative Sensor in Cardiovascular and Inflammatory Disease	29
Growth Differentiation Factor 15 and NT‐proBNP as Blood‐Based Markers of Vascular Brain Injury and Dementia	29
Prognostic Implications of Early and Midrange Readmissions After Acute Heart Failure Hospitalizations: A Report From a Japanese Multicenter Registry	29
Short Physical Performance Battery and Incident Cardiovascular Events Among Older Women	29
Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus	29
Molecular, Cellular, and Clinical Evidence That Sodium‐Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart Failure	29
Dietary Fatty Acids, Macronutrient Substitutions, Food Sources and Incidence of Coronary Heart Disease: Findings From the EPIC‐CVD Case‐Cohort Study Across Nine European Countries	29
Introduction to Hemodynamic Forces Analysis: Moving Into the New Frontier of Cardiac Deformation Analysis	29
Anticancer Therapy–Related Increases in Arterial Stiffness: A Systematic Review and Meta‐Analysis	28
Gut Microbiota‐Dependent Trimethylamine N‐oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS‐TIMI 54 Trial	28
Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?	28
Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United	28
Contaminant Metals as Cardiovascular Risk Factors: A Scientific Statement From the American Heart Association	28
Efficacy and Safety of ProGlide Versus Prostar XL Vascular Closure Devices in Transcatheter Aortic Valve Replacement: The RISPEVA Registry	28
Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome	28
New Electrocardiographic Algorithm for the Diagnosis of Acute Myocardial Infarction in Patients With Left Bundle Branch Block	28
Association Between Black Race, Clinical Severity, and Management of Acute Pulmonary Embolism: A Retrospective Cohort Study	28
Single‐Cell Transcriptomics of Engineered Cardiac Tissues From Patient‐Specific Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile	28
Maternal Coronary Heart Disease, Stroke, and Mortality Within 1, 3, and 5 Years of Delivery Among Women With Hypertensive Disorders of Pregnancy and Pre‐Pregnancy Hypertension	28
JAHASpotlight on Racial and Ethnic Disparities in Cardiovascular Disease	28
Paroxetine Attenuates Cardiac Hypertrophy Via Blocking GRK2 and ADRB1 Interaction in Hypertension	28
Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta‐Analysis Involving 27 Million Patients	28
Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study	28
Effects of Aging on Cardiac Oxidative Stress and Transcriptional Changes in Pathways of Reactive Oxygen Species Generation and Clearance	28
Thromboprophylaxis for Children Post‐Fontan Procedure: Insights From the UNIVERSE Study	28